92 related articles for article (PubMed ID: 2747606)
21. Aberrant expression of cortactin and fascin are effective markers for pathogenesis, invasion, metastasis and prognosis of gastric carcinomas.
Li X; Zheng H; Hara T; Takahashi H; Masuda S; Wang Z; Yang X; Guan Y; Takano Y
Int J Oncol; 2008 Jul; 33(1):69-79. PubMed ID: 18575752
[TBL] [Abstract][Full Text] [Related]
22. [mRNA expression of IGF-IIand HGF in relation to microvascular density, tumor progression and prognosis of gastric carcinoma].
Zhao ZS; Ru GQ; Ma J
Zhonghua Zhong Liu Za Zhi; 2004 Nov; 26(11):673-7. PubMed ID: 15777506
[TBL] [Abstract][Full Text] [Related]
23. Expression of CD44v6 in advanced gastric cancer and its relationship to hematogenous metastasis and long-term prognosis.
Yamaguchi A; Goi T; Yu J; Hirono Y; Ishida M; Iida A; Kimura T; Takeuchi K; Katayama K; Hirose K
J Surg Oncol; 2002 Apr; 79(4):230-5. PubMed ID: 11920780
[TBL] [Abstract][Full Text] [Related]
24. Overexpression of GRP78 and GRP94 are markers for aggressive behavior and poor prognosis in gastric carcinomas.
Zheng HC; Takahashi H; Li XH; Hara T; Masuda S; Guan YF; Takano Y
Hum Pathol; 2008 Jul; 39(7):1042-9. PubMed ID: 18482745
[TBL] [Abstract][Full Text] [Related]
25. Gastric cancer: correlation between clinicopathological factors and survival of patients. II.
Lazăr D; Tăban S; Sporea I; Dema A; Cornianu M; Lazăr E; Goldiş A; Vernic C
Rom J Morphol Embryol; 2009; 50(2):185-94. PubMed ID: 19434309
[TBL] [Abstract][Full Text] [Related]
26. Risk factors for lymph node metastasis in histologically poorly differentiated type early gastric cancer.
Kunisaki C; Takahashi M; Nagahori Y; Fukushima T; Makino H; Takagawa R; Kosaka T; Ono HA; Akiyama H; Moriwaki Y; Nakano A
Endoscopy; 2009 Jun; 41(6):498-503. PubMed ID: 19533552
[TBL] [Abstract][Full Text] [Related]
27. Clinicopathological study of mucinous gastric carcinoma.
Shibuya H; Nishida R; Koide S; Kurokawa J; Okita K
Ann Chir Gynaecol; 2000; 89(4):273-6. PubMed ID: 11204957
[TBL] [Abstract][Full Text] [Related]
28. Paradoxical expression of maspin in gastric carcinomas: correlation with carcinogenesis and progression.
Yu M; Zheng H; Tsuneyama K; Takahashi H; Nomoto K; Xu H; Takano Y
Hum Pathol; 2007 Aug; 38(8):1248-55. PubMed ID: 17490717
[TBL] [Abstract][Full Text] [Related]
29. [Multi-antibody combined determination of lymph node micrometastasis in patients with gastric cancer].
Wang GY; Wang SJ; Li Y; Wang LL; Wang XL; Song ZC; Fan LQ
Ai Zheng; 2004 May; 23(5):559-63. PubMed ID: 15142454
[TBL] [Abstract][Full Text] [Related]
30. MUC 1 core protein as a marker of gallbladder malignancy.
Ghosh M; Kamma H; Kawamoto T; Koike N; Miwa M; Kapoor VK; Krishnani N; Agrawal S; Ohkohchi N; Todoroki T
Eur J Surg Oncol; 2005 Oct; 31(8):891-6. PubMed ID: 15922536
[TBL] [Abstract][Full Text] [Related]
31. The role of thymidine phosphorylase expression in the invasiveness of gastric carcinoma.
Shimaoka S; Matsushita S; Nitanda T; Matsuda A; Nioh T; Suenaga T; Nishimata Y; Akiba S; Akiyama S; Nishimata H
Cancer; 2000 May; 88(10):2220-7. PubMed ID: 10820342
[TBL] [Abstract][Full Text] [Related]
32. [Human epidermal growth factor (h-EGF) in gastric carcinomas].
Fushida S; Yonemura Y; Sugiyama K; Matsumoto H; Kamata T; Miwa K; Miyazaki I
Nihon Geka Gakkai Zasshi; 1988 Dec; 89(12):1965-8. PubMed ID: 3265984
[TBL] [Abstract][Full Text] [Related]
33. High CD40 expression in gastric cancer associated with expanding type histology and liver metastasis.
Lo SS; Wu CW; Chi CW; Li AF; Chen JH; Lui WY
Hepatogastroenterology; 2005; 52(66):1902-4. PubMed ID: 16334803
[TBL] [Abstract][Full Text] [Related]
34. Peritumoral lymphatic microvessel density associated with tumor progression and poor prognosis in gastric carcinoma.
Coşkun U; Akyürek N; Dursun A; Yamaç D
J Surg Res; 2010 Nov; 164(1):110-5. PubMed ID: 19628230
[TBL] [Abstract][Full Text] [Related]
35. [Histological localization of TAG72 in gastric cancers and a clinico-pathological study of the CA72-4 serum values].
Konishi F; Matzunou H; Konishi K; Yamamichi N
Gan No Rinsho; 1990 May; 36(6):691-9. PubMed ID: 2161468
[TBL] [Abstract][Full Text] [Related]
36. [Comparative study on biological difference between gastric cancer and colorectal cancer].
Mai M; Ohta T; Minamoto T; Takahashi Y
Nihon Geka Gakkai Zasshi; 1996 Apr; 97(4):263-8. PubMed ID: 8692141
[TBL] [Abstract][Full Text] [Related]
37. Relationship of p53 and c-erbB-2 expression to histopathological features, Helicobacter pylori infection and prognosis in gastric cancer.
Shun CT; Wu MS; Lin JT; Chen SY; Wang HP; Lee WJ; Wang TH; Chuang SM
Hepatogastroenterology; 1997; 44(14):604-9. PubMed ID: 9164544
[TBL] [Abstract][Full Text] [Related]
38. [Relationship between bFGF mRNA and MMP-9 mRNA expression in gastric carcinoma and their clinicopathological features as well as patients survival].
Zhao ZS; Yao GY; Ru GQ; Ma J; Ruan J
Zhonghua Wai Ke Za Zhi; 2005 Feb; 43(3):169-72. PubMed ID: 15842896
[TBL] [Abstract][Full Text] [Related]
39. The prognostic impact of isolated tumor cells in lymph nodes of T2N0 gastric cancer: comparison of American and Japanese gastric cancer patients.
Fukagawa T; Sasako M; Shimoda T; Sano T; Katai H; Saka M; Mann GB; Karpeh M; Coit DG; Brennan MF
Ann Surg Oncol; 2009 Mar; 16(3):609-13. PubMed ID: 19137375
[TBL] [Abstract][Full Text] [Related]
40. Clinical significance of immunohistochemically-identified lymphatic and/or blood vessel tumor invasion in gastric cancer.
Kim JH; Park SS; Park SH; Kim SJ; Mok YJ; Kim CS; Lee JH; Kim YS
J Surg Res; 2010 Aug; 162(2):177-83. PubMed ID: 20031164
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
